Michael D. Clayman

Insider Reports History

Location
Burlington, MA
Signature
/s/ Mark S. Levine, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael D. Clayman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 19 Nov 2021 By the Michael D.Clayman 2006 Revocable Trust
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 19 Nov 2021 By the Michael D. Clayman Irrevocable Trust
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 19 Nov 2021 By Versant Development Fund III, LLC
Flexion Therapeutics Inc President and CEO, Director Common Stock 0 $8.50 19 Nov 2021 Direct
Flexion Therapeutics Inc President and CEO, Director Performance Restricted Stock Unit Award 0 19 Nov 2021 Direct
Flexion Therapeutics Inc President and CEO, Director Stock Option (right to buy) 0 19 Nov 2021 Direct

Insider Reports Filed by Michael D. Clayman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919121065703-clayman-michael-d-2021-11-19 Flexion Therapeutics Inc 19 Nov 2021 13 -$9,541,675 4 President and CEO, Director 19 Nov 2021, 08:56
/report/000120919121047501-clayman-michael-d-2021-07-19 Flexion Therapeutics Inc 19 Jul 2021 1 $0 4 President and CEO, Director 20 Jul 2021, 20:44
/report/000120919121043522-clayman-michael-d-2021-06-21 Flexion Therapeutics Inc 21 Jun 2021 1 +$13,226 4 President and CEO, Director 28 Jun 2021, 18:04